Bevin O'Neil

Bevin O'Neil serves as the Chief Strategy Officer and VP of Strategy at ECRI since February 2021. O'Neil is also a Partner at Incline GEP, LLC and holds board member positions at Beija-Flor, AMAZINGCOSMETICS, and previously at Enveric Biosciences, Inc., and BioReliance Holdings, Inc. Notably, O'Neil was a Pediatric Indication Manager at the Clinton Health Access Initiative, focusing on improving access to essential medicines for HIV, TB, and malaria in developing countries. Prior experiences include serving on the board of INC Research and Lantheus Medical Imaging, and working as a Principal at Avista Capital Partners, where O'Neil managed multiple private equity investments in healthcare. O'Neil earned a BBA from the University of Michigan in 1999.